{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-108405","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2026-09-17T10:35:51+00:00","discovered_at":"2026-09-17T10:40:02.532478+00:00","generated_at":"2026-09-17T10:40:07.531786+00:00","sec_items":["5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Accendra Health names Kenneth Gardner-Smith as next CEO; Scott Lloyd as Chief Commercial Officer","bullets":["Gardner-Smith, Board member since Mar 2022, to assume CEO early Q4 2026; succeeds retiring Edward Pesicka.","Offer Letter: $1.0M base salary, 130% target bonus, $6M equity grant (25% RSU, 25% PSU, 50% cash PSU), $650K sign-on bonus.","Lloyd to become Chief Commercial Officer effective Oct 5, 2026; ex-Evergreen Nephrology, co-founder of Extrakare.","Pesicka remains CEO until transition, then advisor; Gardner-Smith steps down from two board committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-108405","json":"https://secwatch.observer/filing/0001104659-26-108405.json","markdown":"https://secwatch.observer/filing/0001104659-26-108405.md","text":"https://secwatch.observer/filing/0001104659-26-108405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/0001104659-26-108405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/ach-20260916x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-17T10:40:07.531786+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b60f28cb3","claim":"Edward A. Pesicka departed as Director at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"Mr. Pesicka will remain in the role of President and CEO until Mr. Gardner-Smith assumes the role, at which point Mr. Pesicka will also retire from the Board of Directors, as previously announced.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/0001104659-26-108405-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"6cdfaea235","claim":"Edward A. Pesicka departed as President and Chief Executive Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"He will succeed Edward A. Pesicka, who previously announced his intent to retire in August.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/0001104659-26-108405-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retire"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"d712f79ccc","claim":"Kenneth Gardner-Smith was named as President and Chief Executive Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"On September 17, 2026, Accendra Health, Inc. (the “Company” or “Accendra Health”) announced that it named Kenneth Gardner-Smith as the Company’s next President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000110465926108405/0001104659-26-108405-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"named"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}